TR200003839T2 - Hormon ve kristalleşmeyi engelleyen maddeler içeren transdermal terapi sistemi - Google Patents

Hormon ve kristalleşmeyi engelleyen maddeler içeren transdermal terapi sistemi

Info

Publication number
TR200003839T2
TR200003839T2 TR2000/03839T TR200003839T TR200003839T2 TR 200003839 T2 TR200003839 T2 TR 200003839T2 TR 2000/03839 T TR2000/03839 T TR 2000/03839T TR 200003839 T TR200003839 T TR 200003839T TR 200003839 T2 TR200003839 T2 TR 200003839T2
Authority
TR
Turkey
Prior art keywords
crystallization
therapy system
system containing
containing substances
transdermal therapy
Prior art date
Application number
TR2000/03839T
Other languages
English (en)
Inventor
Robert Klein Peter
Meconi Reinhold
Mller Walter
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200003839T2 publication Critical patent/TR200003839T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/932—Specified use of nanostructure for electronic or optoelectronic application
    • Y10S977/939—Electron emitter, e.g. spindt emitter tip coated with nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Estradiolün Norethisteron asetat ile kombinasyon halinde kontrollü olarak verilmesi için, bir arka tabakadan, Poliakrilat yapistiricilari ve kristallesmeyi engelleyen maddeler kullanilarak imal edilen ve bol miktarda etki maddesi içeren buna bagli bir rezervuardan ve tekrar çikarilabilen bir koruyucu tabakadan ibaret olan pflaster seklindeki bir transdermal terapi sisteminin özelligi, kristallesmeyi engelleyen maddelerin Amino gruplari içeren bir polimer olmasidir.
TR2000/03839T 1998-06-25 1999-06-08 Hormon ve kristalleşmeyi engelleyen maddeler içeren transdermal terapi sistemi TR200003839T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19828273A DE19828273B4 (de) 1998-06-25 1998-06-25 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren

Publications (1)

Publication Number Publication Date
TR200003839T2 true TR200003839T2 (tr) 2001-06-21

Family

ID=7871950

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03839T TR200003839T2 (tr) 1998-06-25 1999-06-08 Hormon ve kristalleşmeyi engelleyen maddeler içeren transdermal terapi sistemi

Country Status (23)

Country Link
US (1) US6899894B1 (tr)
EP (1) EP1089719B1 (tr)
JP (1) JP2002518430A (tr)
KR (1) KR100550888B1 (tr)
CN (1) CN1148172C (tr)
AR (1) AR019715A1 (tr)
AT (1) ATE215819T1 (tr)
AU (1) AU768755B2 (tr)
BR (1) BR9912210A (tr)
CA (1) CA2335582C (tr)
CZ (1) CZ300707B6 (tr)
DE (2) DE19828273B4 (tr)
DK (1) DK1089719T3 (tr)
ES (1) ES2177290T3 (tr)
HU (1) HUP0102498A3 (tr)
IL (2) IL140434A0 (tr)
NZ (1) NZ509015A (tr)
PL (1) PL193080B1 (tr)
PT (1) PT1089719E (tr)
TR (1) TR200003839T2 (tr)
TW (1) TW533084B (tr)
WO (1) WO1999066901A2 (tr)
ZA (1) ZA200007751B (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
DE60204229T2 (de) * 2002-12-02 2006-02-02 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US20080286348A1 (en) * 2007-05-16 2008-11-20 Todhunter John A Secured transdermal delivery system
US9155725B2 (en) * 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
JP6054013B2 (ja) * 2008-02-27 2016-12-27 久光製薬株式会社 貼付製剤
JP5547065B2 (ja) 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
CN103933018A (zh) * 2013-01-18 2014-07-23 江苏康倍得药业有限公司 一种透皮给药系统
CN108785286A (zh) * 2017-04-28 2018-11-13 日东电工株式会社 透皮吸收制剂

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0745400B2 (ja) * 1986-03-29 1995-05-17 日東電工株式会社 外用医薬製剤
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
DE3743946A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
DE3939376C1 (tr) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
JPH04261119A (ja) * 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤
CA2077369A1 (en) 1991-09-09 1993-03-10 Hitoshi Akemi Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
US5286810A (en) * 1992-08-07 1994-02-15 Srchem Incorporated Salt of polymer from maleic acid, polyamind and ammonia
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US5683711A (en) * 1993-04-20 1997-11-04 Hexal Pharma Gmbh Active ingredient patch
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
AU2402495A (en) 1994-05-05 1995-11-29 Merck Frosst Canada Inc. Topical polymeric drug delivery system
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5951999A (en) * 1997-02-21 1999-09-14 Adhesives Research, Inc. Transdermal pressure sensitive adhesive drug delivery system
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
DE59901202D1 (de) 2002-05-16
KR20010053132A (ko) 2001-06-25
DK1089719T3 (da) 2002-08-05
CN1310616A (zh) 2001-08-29
AU4508699A (en) 2000-01-10
CA2335582A1 (en) 1999-12-29
TW533084B (en) 2003-05-21
WO1999066901A3 (de) 2000-03-23
PL345455A1 (en) 2001-12-17
JP2002518430A (ja) 2002-06-25
PL193080B1 (pl) 2007-01-31
DE19828273A1 (de) 1999-12-30
NZ509015A (en) 2004-01-30
EP1089719A2 (de) 2001-04-11
EP1089719B1 (de) 2002-04-10
CZ300707B6 (cs) 2009-07-22
ZA200007751B (en) 2001-07-18
ATE215819T1 (de) 2002-04-15
HUP0102498A3 (en) 2002-01-28
DE19828273B4 (de) 2005-02-24
AU768755B2 (en) 2004-01-08
IL140434A (en) 2006-10-05
WO1999066901A2 (de) 1999-12-29
ES2177290T3 (es) 2002-12-01
US6899894B1 (en) 2005-05-31
CZ20004798A3 (en) 2001-05-16
PT1089719E (pt) 2002-09-30
KR100550888B1 (ko) 2006-02-10
CN1148172C (zh) 2004-05-05
IL140434A0 (en) 2002-02-10
CA2335582C (en) 2006-04-11
BR9912210A (pt) 2001-04-10
HUP0102498A2 (hu) 2001-11-28
AR019715A1 (es) 2002-03-13

Similar Documents

Publication Publication Date Title
TR200003839T2 (tr) Hormon ve kristalleşmeyi engelleyen maddeler içeren transdermal terapi sistemi
TR200102916T2 (tr) Nötrleştirilmiş basınca duyarlı akrilat yapışkanlar ihtiva eden transdermal terapötik sistem
TR200100289T2 (tr) Transdermal hormon uygulaması için estradiol içerkli flaster
TR199902608T2 (tr) Bogaz yumusatici bilesimler.
MY100066A (en) Multicompartmentalized dermal and transdermal patches.
AU3636184A (en) Active compound release systems containing polyisobutylenes
BR9915772A (pt) Substrato revestido com adesivo
NO932671L (no) Venekateterbandasje med vindu
DK179688D0 (da) Transdermale terapeutiske systemer for kombinationer af aktive stoffer
GR3024097T3 (en) Transdermal therapeutic systems.
DE60022887D1 (de) Kosmetische streifen mit einem mittel zur induzierung einer temperaturänderung
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
MY108446A (en) Absorbent article
IL73935A0 (en) Therapeutic active compound release systems
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
TR199800644T2 (tr) Bir apoptoz inhibitörü olarak y-RAR antagonist ligandi ya da alfa-RAR antagonist ligandi.
CA2146723A1 (en) Percutaneous absorption preparation
AU2990484A (en) Acrylic adhesives
TR200101933T2 (tr) Ayrılabilen yapışkanlar.
DE59803454D1 (de) Transdermales therapeutisches system mit dem wirkstoff scopolaminbase
ID26591A (id) Satu pengeras untuk digunakan dalam perekat-perekat berbahan dasar urea-formaldehida dan urea-melamin-formaldehida, satu komposisi perekat yang terdiri dari pengerak tadi dan penggunaannya
GB1292545A (en) Medical plaster
ES279820U (es) Modulo replegable y encolable para envio postal de mensajes de gran tirada.
TR200102079T2 (tr) Yapışkan kilitli zarf
TR200102915T2 (tr) Etkili bir nöroleptik ilaç ihtiva eden transdermal terapötik sistem.